Skip to content

Treatment of post-stroke anxiety with Jin's three-needle acupuncture Clinical efficacy observation

Standardized application and clinical evaluation of Jin's three-needle acupuncture for stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058992
Enrollment
Unknown
Registered
2022-04-22
Start date
2022-08-17
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke anxiety

Interventions

Sham Acupuncture Group:1.Basic western medicine therapy
2.Modern rehabilitation therapy
3.Sham acupuncture treatment.
Acupuncture Group:1.Basic western medicine treatment
3.Jin's three-needle-regulating-shen acupuncture method.

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age 30-75 years old, both male and female; 2.Patients with =2 strokes (cerebral infarction/cerebral hemorrhage); 3.Anxiety disorder meets the diagnostic criteria for moderate generalized anxiety disorder (1417 points, primary school>20 points, junior high school and above>24 points ), can cooperate with acupuncture, rehabilitation training and related basic treatment; 6.Those who understand the test and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Transient ischemic attack, reversible neurological deficit; 2.Patients with severe anxiety, or other mental illnesses (such as depression, mania, schizophrenia, etc.) 3.Those who have been confirmed by examination that the neurological deficit is caused by diseases such as brain tumor, brain trauma, cerebral vascular malformation, and brain parasites, and whose life expectancy is less than 1 year for reasons other than stroke; 4.Patients with contraindications to acupuncture, or patients with stroke combined with severe circulatory system, respiratory system, digestive system, urinary system, endocrine system, and hematopoietic system and other primary diseases that cannot be controlled by conventional medication; patients with tumors, severe infection , patients with water, electrolyte and acid-base balance disorders; or other patients with abnormal examination judged not suitable for participating in this trial; 5.Those with severe aphasia, sleep apnea, deafness, severe cognitive impairment and even unable to communicate normally; or those who are participating in other clinical research trials; 6.Women who are pregnant or planning to become pregnant.

Design outcomes

Primary

MeasureTime frame
Hamilton Anxiety Scale;

Secondary

MeasureTime frame
Self-Rating Anxiety Scale;National Institute Health stroke scale;Modified Barthel Index;functional MRI;

Countries

china

Contacts

Public ContactMeichen li

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

2386471273@qq.com13533366452

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026